[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20050091L - Fremgangsmater for fremstilling av fibrinogen - Google Patents

Fremgangsmater for fremstilling av fibrinogen

Info

Publication number
NO20050091L
NO20050091L NO20050091A NO20050091A NO20050091L NO 20050091 L NO20050091 L NO 20050091L NO 20050091 A NO20050091 A NO 20050091A NO 20050091 A NO20050091 A NO 20050091A NO 20050091 L NO20050091 L NO 20050091L
Authority
NO
Norway
Prior art keywords
methods
fibrinogen
preparing fibrinogen
preparing
purification
Prior art date
Application number
NO20050091A
Other languages
English (en)
Inventor
David Evans
Sarah Kingsland
Peter Feldman
Robert Clemmitt
Original Assignee
Nat Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority filed Critical Nat Blood Authority
Publication of NO20050091L publication Critical patent/NO20050091L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Anvendelse av immobilisert metallion-affinitetskromatografi for separering av fibrinogen fra plasminogen, for rensing av fibrinogen og minst ett annet protein, for eksempel plasminogen og for samrensning av fibrinogen og faktor XIII.
NO20050091A 2002-07-10 2005-01-06 Fremgangsmater for fremstilling av fibrinogen NO20050091L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216001.8A GB0216001D0 (en) 2002-07-10 2002-07-10 Process and composition
PCT/GB2003/002928 WO2004007533A1 (en) 2002-07-10 2003-07-07 Processes for the preparation of fibrinogen

Publications (1)

Publication Number Publication Date
NO20050091L true NO20050091L (no) 2005-04-06

Family

ID=9940203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050091A NO20050091L (no) 2002-07-10 2005-01-06 Fremgangsmater for fremstilling av fibrinogen

Country Status (17)

Country Link
US (1) US7816495B2 (no)
EP (1) EP1519944B1 (no)
JP (1) JP4324102B2 (no)
AT (1) ATE449104T1 (no)
AU (1) AU2003244850B2 (no)
BR (1) BRPI0312521B8 (no)
CA (1) CA2491716C (no)
DE (1) DE60330146D1 (no)
DK (1) DK1519944T3 (no)
EC (1) ECSP055584A (no)
ES (1) ES2332780T3 (no)
GB (1) GB0216001D0 (no)
IL (1) IL165988A0 (no)
MX (1) MXPA05000395A (no)
NO (1) NO20050091L (no)
PL (1) PL210616B1 (no)
WO (1) WO2004007533A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
CN101010333B (zh) 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
EP1817339B1 (en) * 2004-11-23 2012-01-11 ZymoGenetics, Inc. Purification of recombinant human factor xiii
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101067131B (zh) * 2007-04-30 2011-08-17 华南理工大学 一种利用亲和层析法分离纯化纤溶酶的方法
PL2268267T3 (pl) 2008-04-21 2017-12-29 Novo Nordisk Health Care Ag Kompozycja sucha transglutaminazy
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
ES2586698T3 (es) 2010-09-20 2016-10-18 Octapharma Ag Proceso para la producción de fibrinógeno
WO2013135684A1 (en) 2012-03-13 2013-09-19 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
US9243239B2 (en) * 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CA3001625A1 (en) 2015-11-09 2017-05-18 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US10695395B2 (en) * 2015-12-23 2020-06-30 Phoenix Tissue Repair, Inc. Collagen 7 compositions and methods of using the same
EP3612214A4 (en) 2017-04-17 2021-01-20 The Regents of the University of Colorado, A Body Corporate OPTIMIZATION OF ALTERNATIVE ENZYMOTHERAPY FOR THE TREATMENT OF HOMOCYSTINURIA
WO2022133973A1 (en) 2020-12-25 2022-06-30 Guangzhou Bioseal Biotech Co., Ltd. Fibrinogen aseptic filtration
IL310285A (en) 2021-08-13 2024-03-01 Biotest Ag Fibrinogen preparations and preparation methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618784B1 (fr) 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US5445958A (en) * 1987-12-22 1995-08-29 National Blood Authority Process for purifying blood clotting factors
JPH02193913A (ja) 1989-01-20 1990-07-31 Denki Kagaku Kogyo Kk パイロジエンを除去する方法
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
AU4693093A (en) 1992-07-27 1994-02-14 Haemacure Biotech Inc. Biocompatible surgical implant
JPH06138127A (ja) 1992-10-26 1994-05-20 Tanabe Seiyaku Co Ltd 標識フィブリノーゲンおよびその用途
US5395923A (en) 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
WO1995025748A1 (en) 1994-03-18 1995-09-28 Baxter International Inc. Topical fibrinogen complex
JPH0812586A (ja) 1994-07-01 1996-01-16 Mikimoto Pharmaceut Co Ltd 抗プラスミン剤
GB9424732D0 (en) 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
JPH08333387A (ja) 1995-06-12 1996-12-17 Mitsubishi Materials Corp タンパク質分離精製方法
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US5981254A (en) 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
AUPP521298A0 (en) 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
JP2001270900A (ja) 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd フィブリノゲンのウイルス不活化法

Also Published As

Publication number Publication date
ATE449104T1 (de) 2009-12-15
AU2003244850A1 (en) 2004-02-02
AU2003244850B2 (en) 2009-06-25
JP2006505508A (ja) 2006-02-16
US20070042944A1 (en) 2007-02-22
PL374080A1 (en) 2005-09-19
EP1519944B1 (en) 2009-11-18
DK1519944T3 (da) 2010-03-29
ES2332780T3 (es) 2010-02-12
GB0216001D0 (en) 2002-08-21
MXPA05000395A (es) 2005-09-30
WO2004007533A1 (en) 2004-01-22
JP4324102B2 (ja) 2009-09-02
EP1519944A1 (en) 2005-04-06
DE60330146D1 (de) 2009-12-31
BRPI0312521B8 (pt) 2021-05-25
IL165988A0 (en) 2006-01-15
PL210616B1 (pl) 2012-02-29
BRPI0312521B1 (pt) 2019-06-25
CA2491716A1 (en) 2004-01-22
US7816495B2 (en) 2010-10-19
CA2491716C (en) 2012-02-07
ECSP055584A (es) 2005-07-06
BR0312521A (pt) 2005-04-19

Similar Documents

Publication Publication Date Title
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
NO20091976L (no) Nye forbindelser
DE60107687D1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
BRPI0414599A (pt) pirrol-indóis substituìdos
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
MXPA02004666A (es) Gelatinas recombinantes.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
NO20063193L (no) Fusjonerte pyrrolokarbazoler og fremgangsmater for fremstilling derav
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
NO20055741D0 (no) Nye kjemiske forbindelser
GB0216002D0 (en) Process and composition
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
ATE328904T1 (de) Modulation der tetraspanin funktion
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen